Greenland Capital Management’s Verve Therapeutics VERV Stock Holding History

Greenland Capital Management’s Portfolio VERV Stock Details VERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,506	Closed	-$556K	–	419
2025 Q3	$556K	Hold	49,506	–	–	0.06%	210
2025 Q2	$556K	Buy	+49,506	New	+$282K	0.06%	224

Other funds holding VERV

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Greenland Capital Management's VERV Position: Q4 2025 in Review

Greenland Capital Management sold out of Verve Therapeutics (VERV) in Q4 2025, closing a stake of 49,506 shares — an estimated $556K sold.

Greenland Capital Management first reported a position in VERV in Q2 2025 and held it in 2 quarters. The position peaked at $556K in Q3 2025. 1 fund tracked by Wall St. Rank holds VERV as of Q4 2025.

Greenland Capital Management reported no remaining Verve Therapeutics position as of Q4 2025 after selling out during the quarter.
Greenland Capital Management sold 49,506 Verve Therapeutics shares in Q4 2025, an estimated $556K.
Greenland Capital Management first reported a position in Verve Therapeutics in Q2 2025 and held it in 2 quarters.
Greenland Capital Management's Verve Therapeutics position peaked at $556K in Q3 2025.
1 fund tracked by Wall St. Rank held Verve Therapeutics as of Q4 2025.

Based on Greenland Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.